BRAF and thyroid gland papillary carcinoma: Approximately 90% of B-Raf mutations found in melanomas and papillary thyroid carcinomas are point mutations resulting in substitution of of a valine with glutamic acid at amino acid 600 (B-Raf V600E) [30].